Clinical trials
4 active studies led by Mucosa Innovations, S.L., of 6 in all
Source: ClinicalTrials.gov, Studies with Mucosa Innovations, S.L. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 5Markets in public records
- 0Regions & countries
- 4Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by Mucosa Innovations, S.L. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on Mucosa Innovations, S.L.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
See them on ClinicalTrials.gov (opens in a new tab)
Trials over time
Studies Mucosa Innovations, S.L. leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with Mucosa Innovations, S.L. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show Mucosa Innovations, S.L.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets Mucosa Innovations, S.L. is in.
From our blog
Stories on the topics Mucosa Innovations, S.L. works in.
Bone and Joint Health: Supplements for an Ageing Population
1.71 billion people live with musculoskeletal conditions, including 528 million with osteoarthritis. Evidence…
Read
Eye Health Supplements: Screens, Ageing and Vision
2.2 billion people have a vision impairment. One supplement formula has strong trial evidence, but only for a…
Read
Women's Health Supplements: A Growing Focus
Anaemia affects about half a billion women worldwide, and folic acid before pregnancy prevents serious birth…
ReadSearch all reports for Mucosa Innovations, S.L. All companies